Science & Environment

Research

The Latest

SDSC, Calit2 Awarded $1.4 Million NSF Grant for New Bioinformatics Tools

Researchers at the San Diego Supercomputer Center (SDSC) and the California Institute for Telecommunications and Information Technology (Calit2) at the University of California, San Diego, have been awarded a three-year, $1.4 million grant from the National Science Foundation (NSF) to create a Kepler Scientific Workflow System module. Researchers will develop new tools to help manage ever-growing data sets used in next-generation DNA sequencing.

Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements

Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results appeared Oct. 12 in the Journal of the American Medical Association.

Fueling Hope

Chemistry lecturer teaches high school students how to power combustion engine using coffee grounds—but hopes they will also learn love for university life

Genetically Influenced Responses to Alcohol Affect Brain Activation

A study by researchers at the University of California, San Diego School of Medicine suggests that differences in brain activation in individuals with a low level of response to alcohol may contribute to their inability to recognize modest levels of alcohol intoxication. Their findings could provide the potential to identify individuals who are at risk for developing an alcohol-use disorder before it develops – in essence, providing a marker for this vulnerability.

Simple Genetic Circuit Forms Stripes

Many living things have stripes, but the developmental processes that create these and other patterns are complex and difficult to untangle.

UC San Diego School of Medicine Launches Hepatitis C Clinical Trials

A collaborative partnership between the UC San Diego Liver Center and Antiviral Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus (HCV), focused on developing more effective and well-tolerated HCV treatments.